Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety Assessment of T1580 (ciclosporin) versus Vehicle in Dry Eye Disease
2015-005405-36Phase 3Completed
- Sponsor
- Laboratoires Théa
- Start
- Apr 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dry eye syndrome (DED) comparing T1580 (ciclosporin) with Vehicle control (2 arms). Primary endpoint: Change from baseline in corneal fluorescein staining. Started Apr 2016; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2015-005405-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005405-36.